Advertisement







Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 49:1750, doi:10.1016/j.jacc.2007.02.015 (Published online 3 April 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.02.015v1
49/16/1750    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monahan, K. D.
Right arrow Articles by Ray, C. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Monahan, K. D.
Right arrow Articles by Ray, C. A.
Related Collections
Right arrowRelated Articles

CORRESPONDENCE: LETTER TO THE EDITOR

Effect of Polyunsaturated Fatty Acids on Baroreflex Function in Heart Failure Patients

Kevin D. Monahan, PhD* and Chester A. Ray, PhD

* Penn State Heart and Vascular Institute, The Milton S. Hershey Medical Center, Campus Box H047, 500 University Drive, Hershey, Pennsylvania 17033-2390 (Email: kmonahan{at}psu.edu).


Recently in the Journal, Radaelli et al. (1) reported that 4 months of dietary polyunsaturated fatty acid (PUFA) supplementation enhanced baroreflex control of the circulation in heart failure patients. Augmented cardiac-vagal baroreflex control was suggested from increased bradycardiac responses to neck suction as well as enhanced cardiac period fluctuations during spontaneous blood pressure oscillations after PUFA supplementation. These effects of PUFAs on the cardiac-vagal arm of the baroreflex in heart failure patients were impressive and may be of clinical importance.

Based on the detrimental role sympathoexcitation is believed to exert in heart failure, a separate but equally important question is the effect that PUFAs exert on both basal and reflexive measures of sympathetic outflow. To address this question, Radaelli et al. (1) used several indirect indices. First, increased low frequency heart rate variability after PUFA supplementation was used as evidence of reduced sympathetic activity at rest (1). Second, a greater depressor response to neck suction, which likely is mediated via both cardiac (vagal and sympathetic) and peripheral (sympathetic) effects, after PUFA supplementation, was suggested to indicate enhanced sympathoinhibitory baroreflex function (1). As pointed out, these effects of PUFAs in heart failure patients may need to be confirmed using more robust measures of sympathetic outflow, which should also include responses to sympathoexcitatory stimuli (2).

To date, only a single study performed in humans has determined the effect that PUFA supplementation exerts on a direct measure of sympathetic outflow (muscle sympathetic nerve activity [MSNA]) (3). In that study we demonstrated that PUFA supplementation had no effect on MSNA at rest (against our hypothesis that it would reduce it). Furthermore, we observed augmented (not depressed as we hypothesized) increases in MSNA during several distinct sympathoexcitatory stressors (exercise and cold stress) in young healthy adults (3). Because sympathetic outflow at rest is increased and reflex responses to baroreflex activation/deactivation may be impaired in heart failure patients, it is unclear whether similar effects of PUFAs on MSNA would be observed in heart failure patients. Accordingly, it appears that studies employing more robust methodologies are needed to more definitively determine the effect that PUFAs exert on basal and reflexive (both sympathoinhibitory and sympathoexcitatory during baroreflex and nonbaroreflex stimuli) regulation of sympathetic outflow in heart failure patients.


    References
 Top
 References
 
1. Radaelli A, Cazzaniga M, Viola A, et al. Enhanced baroreceptor control of the cardiovascular system by polyunsaturated fatty acids in heart failure patients J Am Coll Cardiol 2006;48:1600-1606.[Abstract/Free Full Text]

2. Floras J, Bagai A. Polyunsaturated fatty acids and the post-infarct patient: a recipe for baroreflex health? J Am Coll Cardiol 2006;48:1607-1609.[Free Full Text]

3. Monahan KD, Wilson TE, Ray CA. Omega-3 fatty acid supplementation augments sympathetic nerve activity responses to physiological stressors in humans Hypertension 2004;44:732-738.[Abstract/Free Full Text]


Related Articles

Effect of Polyunsaturated Fatty Acids on Baroreflex Function in Heart Failure Patients
Kevin D. Monahan and Chester A. Ray
J. Am. Coll. Cardiol. 2007 49: 1750. [Full Text] [PDF]

Reply
Alberto U. Ferrari, Giuseppe Mancia, and Alberto Radaelli
J. Am. Coll. Cardiol. 2007 49: 1750-1751. [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.02.015v1
49/16/1750    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monahan, K. D.
Right arrow Articles by Ray, C. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Monahan, K. D.
Right arrow Articles by Ray, C. A.
Related Collections
Right arrowRelated Articles

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement